ConductScience.org, home

Paper21990358

Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.

Schmidt J and 5 others. J Biol Chem, 2011. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells. Papers, record 21990358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21990358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.
PubMed
Journal
J Biol Chem
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2021-10-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmidt JJulien
2Guillaume PPhilippe
3Irving MMelita
4Baumgaertner PPetra
5Speiser DDaniel
6Luescher IFImmanuel F

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD8-Positive T-LymphocytesMajor topic
HLA-A2 AntigenMajor topic
HistidineMajor topic
NickelMajor topic
Nitrilotriacetic AcidMajor topic
PeptidesMajor topic
Humans
MART-1 Antigen
Staining and Labeling

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119777993Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.Cancer Immun2009https://conductscience.org/library/papers/19777993PubMed
211371361A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex.Immunity2001https://conductscience.org/library/papers/11371361PubMed
315905522Soluble MHC-peptide complexes induce rapid death of CD8+ CTL.J Immunol2005https://conductscience.org/library/papers/15905522PubMed
416642995Double-hexahistidine tag with high-affinity binding for protein immobilization, purification, and detection on ni-nitrilotriacetic acid surfaces.Anal Chem2006https://conductscience.org/library/papers/16642995PubMed
516826567Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments.Proteomics2006https://conductscience.org/library/papers/16826567PubMed
617306825Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens.J Immunol Methods2007https://conductscience.org/library/papers/17306825PubMed
712374858Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12374858PubMed
819876964Insight into the complexation mode of bis(nitrilotriacetic acid) (NTA) ligands with Ni(2+) involved in the labeling of histidine-tagged proteins.Chemistry2009https://conductscience.org/library/papers/19876964PubMed
910796983Streptavidin-biotin binding energetics.Biomol Eng1999https://conductscience.org/library/papers/10796983PubMed
109344407BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip.Anal Biochem1997https://conductscience.org/library/papers/9344407PubMed
1119330843Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells.Biotechnol Prog2009https://conductscience.org/library/papers/19330843PubMed
1219998338Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma.Int J Cancer2010https://conductscience.org/library/papers/19998338PubMed
1312555674Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.Eur J Immunol2002https://conductscience.org/library/papers/12555674PubMed
1416951353Fluorescence-activated cell sorting and cloning of bona fide CD8+ CTL with reversible MHC-peptide and antibody Fab' conjugates.J Immunol2006https://conductscience.org/library/papers/16951353PubMed
1521256056Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.Immunity2011https://conductscience.org/library/papers/21256056PubMed
167830771CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.Nature1995https://conductscience.org/library/papers/7830771PubMed
1719650657Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules.Bioconjug Chem2009https://conductscience.org/library/papers/19650657PubMed
1820164930TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.Nature2010https://conductscience.org/library/papers/20164930PubMed
1919235144Oligohis-tags: mechanisms of binding to Ni2+-NTA surfaces.J Mol Recognit2009https://conductscience.org/library/papers/19235144PubMed
2019125886Tricks with tetramers: how to get the most from multimeric peptide-MHC.Immunology2009https://conductscience.org/library/papers/19125886PubMed

See all 35 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42548059Peptide exchange-competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers.J Immunol2026https://conductscience.org/library/papers/42548059PubMed
41709576Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homing.Mol Ther2026https://conductscience.org/library/papers/41709576PubMed
38053994Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.Front Immunol2023https://conductscience.org/library/papers/38053994PubMed
37280206Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.Nat Commun2023https://conductscience.org/library/papers/37280206PubMed
35228747Bystander T cells in cancer immunology and therapy.Nat Cancer2022https://conductscience.org/library/papers/35228747PubMed
34739845Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.Cancer Cell2021https://conductscience.org/library/papers/34739845PubMed
33972472MHC multimer: A Molecular Toolbox for Immunologists.Mol Cells2021https://conductscience.org/library/papers/33972472PubMed
33796916Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen.Cancer Immunol Immunother2021https://conductscience.org/library/papers/33796916PubMed
33665637Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.Cell Rep Med2021https://conductscience.org/library/papers/33665637PubMed
33539685Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents.Curr Protoc2021https://conductscience.org/library/papers/33539685PubMed
32695101Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal.Front Immunol2020https://conductscience.org/library/papers/32695101PubMed
31969886High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.Front Immunol2019https://conductscience.org/library/papers/31969886PubMed
29545564Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.Nat Commun2018https://conductscience.org/library/papers/29545564PubMed
28975614T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.Eur J Immunol2018https://conductscience.org/library/papers/28975614PubMed
28724801TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.JCI Insight2017https://conductscience.org/library/papers/28724801PubMed
28604446Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.Transplantation2017https://conductscience.org/library/papers/28604446PubMed
26635796Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.Front Immunol2015https://conductscience.org/library/papers/26635796PubMed
23908656Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.Front Immunol2013https://conductscience.org/library/papers/23908656PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACSM36296PubTator's text mininghttps://conductscience.org/library/genes/6296NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
MLANA2315PubTator's text mininghttps://conductscience.org/library/genes/2315NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21990358

GET https://conductscience.org/api/papers/v1/21990358/references?page=2